Quinolines and their therapeutic use

Details for Australian Patent Application No. 2006296397 (hide)

Owner Pulmagen Therapeutics (Asthma) Limited

Inventors Ray, Nicholas Charles; Hynd, George; Harrison, Trevor Keith; Griffon, Yann; Montana, John Gary; Crackett, Peter; Finch, Harry; Arienzo, Rosa; Cramp, Michael Colin

Agent Griffith Hack

Pub. Number AU-B-2006296397

PCT Pub. Number WO2007/036743

Priority 0519969.0 30.09.05 GB; 0610551.4 26.05.06 GB

Filing date 29 September 2006

Wipo publication date 5 April 2007

Acceptance publication date 15 December 2011

International Classifications

C07D 215/00 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/47 (2006.01) - Quinolines

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/036743 Priority application(s): WO2007/036743

29 July 2010 Alteration of Name

  The name of the applicant has been altered to Pulmagen Therapeutics (Asthma) Limited

15 December 2011 Application Accepted

  Published as AU-B-2006296397

12 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006296399-Interleukin-13 antibody composition

2006296396-Fuel compositions containing fuel additive